{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T22:13:50Z","timestamp":1790979230723,"version":"4.1.0"},"reference-count":94,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Veterinary Clinics of North America: Equine Practice"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.cveq.2018.11.004","type":"journal-article","created":{"date-parts":[[2019,3,11]],"date-time":"2019-03-11T09:42:53Z","timestamp":1552297373000},"page":"217-241","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Cardiac Therapeutics in Horses"],"prefix":"10.1016","volume":"35","author":[{"given":"Adam","family":"Redpath","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Bowen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cveq.2018.11.004_bib1","first-page":"115","article-title":"Classification of antidysrhythmic drugs","volume":"1","author":"Vaughan Williams","year":"1975","journal-title":"Pharmacol Ther B"},{"key":"10.1016\/j.cveq.2018.11.004_bib2","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1136\/vr.77.33.951","article-title":"The use of quinidine sulphate for the treatment of atrial fibrillation in twelve horses","volume":"77","author":"Glendinning","year":"1965","journal-title":"Vet Rec"},{"key":"10.1016\/j.cveq.2018.11.004_bib3","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1365-2885.1994.tb00245.x","article-title":"Effect of drug formulation and feeding on the pharmacokinetics of orally administered quinidine in the horse","volume":"17","author":"Bouckaert","year":"1994","journal-title":"J\u00a0Vet Pharmacol Ther"},{"key":"10.1016\/j.cveq.2018.11.004_bib4","doi-asserted-by":"crossref","first-page":"938","DOI":"10.2460\/ajvr.1981.42.06.938","article-title":"Pharmacokinetic analysis of intravenously and orally administered quinidine in horses","volume":"42","author":"McGuirk","year":"1981","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.cveq.2018.11.004_bib5","series-title":"Cardiology of the horse","first-page":"179","article-title":"Arrhythmias","author":"Reef","year":"1999"},{"key":"10.1016\/j.cveq.2018.11.004_bib6","series-title":"The horses: disease and clinical management","first-page":"137","article-title":"Caerdiac arrhythmias","author":"Marr","year":"1995"},{"key":"10.1016\/j.cveq.2018.11.004_bib7","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1365-2885.1994.tb00243.x","article-title":"The pharmacokinetics and pharmacodynamics of procainamide in horses after intravenous administration","volume":"17","author":"Ellis","year":"1994","journal-title":"J\u00a0Vet Pharmacol Ther"},{"key":"10.1016\/j.cveq.2018.11.004_bib8","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0749-0739(17)30690-9","article-title":"Cardiovascular drugs. Their pharmacology and use in horses","volume":"3","author":"Muir","year":"1987","journal-title":"Vet Clin North Am Equine Pract"},{"key":"10.1016\/j.cveq.2018.11.004_bib9","doi-asserted-by":"crossref","first-page":"434","DOI":"10.2746\/042516401776254871","article-title":"Effects of intravenous lidocaine overdose on cardiac electrical activity and blood pressure in the horse","volume":"33","author":"Meyer","year":"2001","journal-title":"Equine Vet J"},{"key":"10.1016\/j.cveq.2018.11.004_bib10","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/evj.12699","article-title":"Successful use of lipid emulsion to resuscitate a foal after intravenous lidocaine induced cardiovascular collapse","volume":"49","author":"Vieitez","year":"2017","journal-title":"Equine Vet J"},{"key":"10.1016\/j.cveq.2018.11.004_bib11","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1365-2885.1987.tb00079.x","article-title":"Pharmacokinetics of antipyrine, acetaminophen and lidocaine in fed and fasted horses","volume":"10","author":"Engelking","year":"1987","journal-title":"J\u00a0Vet Pharmacol Ther"},{"key":"10.1016\/j.cveq.2018.11.004_bib12","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1136\/vr.144.10.259","article-title":"Use of phenytoin to treat digitalis-induced cardiac arrhythmias in a miniature Shetland pony","volume":"144","author":"Wijnberg","year":"1999","journal-title":"Vet Rec"},{"key":"10.1016\/j.cveq.2018.11.004_bib13","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/j.1939-1676.2004.tb02557.x","article-title":"Phenytoin sodium as a treatment for ventricular dysrhythmia in horses","volume":"18","author":"Wijnberg","year":"2004","journal-title":"J\u00a0Vet Intern Med"},{"key":"10.1016\/j.cveq.2018.11.004_bib14","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/jvim.12496","article-title":"Antiarrhythmic and electrophysiologic effects of flecainide on acutely induced atrial fibrillation in healthy horses","volume":"29","author":"Haugaard","year":"2015","journal-title":"J\u00a0Vet Intern Med"},{"key":"10.1016\/j.cveq.2018.11.004_bib15","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1056\/NEJM199103213241201","article-title":"Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial","volume":"324","author":"Echt","year":"1991","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cveq.2018.11.004_bib16","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1292\/jvms.62.711","article-title":"Safe and efficacious dosage of flecainide acetate for treating equine atrial fibrillation","volume":"62","author":"Ohmura","year":"2000","journal-title":"J\u00a0Vet Med Sci"},{"key":"10.1016\/j.cveq.2018.11.004_bib17","doi-asserted-by":"crossref","first-page":"609","DOI":"10.2746\/0425164044864516","article-title":"Use of intravenous flecainide in horses with naturally-occurring atrial fibrillation","volume":"36","author":"van Loon","year":"2004","journal-title":"Equine Vet J"},{"issue":"Suppl 1","key":"10.1016\/j.cveq.2018.11.004_bib18","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s11259-007-0045-0","article-title":"Treatment of chronic atrial fibrillation in the horse with flecainide: personal observation","volume":"31","author":"Birettoni","year":"2007","journal-title":"Vet Res Commun"},{"key":"10.1016\/j.cveq.2018.11.004_bib19","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1939-1676.2006.tb02844.x","article-title":"Successful conversion of equine atrial fibrillation using oral flecainide","volume":"20","author":"Risberg","year":"2006","journal-title":"J\u00a0Vet Intern Med"},{"key":"10.1016\/j.cveq.2018.11.004_bib20","first-page":"759","article-title":"Sudden death of a horse with supraventricular tachycardia following oral administration of flecainide acetate","volume":"24","author":"Dembek","year":"2014","journal-title":"J\u00a0Vet Emerg Crit Care (San Antonio)"},{"key":"10.1016\/j.cveq.2018.11.004_bib21","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.2460\/javma.252.11.1409","article-title":"Treatment of recent-onset atrial fibrillation with quinidine and flecainide in Thoroughbred racehorses: 107 cases (1987\u20132014)","volume":"252","author":"Takahashi","year":"2018","journal-title":"J\u00a0Am Vet Med Assoc"},{"key":"10.1016\/j.cveq.2018.11.004_bib22","doi-asserted-by":"crossref","first-page":"109F","DOI":"10.1016\/0002-9149(93)90973-G","article-title":"Preliminary results of the Cardiac Arrest Study Hamburg (CASH). CASH investigators","volume":"72","author":"Siebels","year":"1993","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cveq.2018.11.004_bib23","series-title":"Equine clinical pharmacology","first-page":"193","article-title":"Drugs acting on the cardiovascular system","author":"Bowen","year":"2004"},{"key":"10.1016\/j.cveq.2018.11.004_bib24","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2460\/ajvr.70.2.223","article-title":"Use of propafenone for conversion of chronic atrial fibrillation in horses","volume":"70","author":"De Clercq","year":"2009","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.cveq.2018.11.004_bib25","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0160-5402(90)90035-J","article-title":"Propafenone kinetics in the horse. Comparative analysis of compartmental and noncompartmental models","volume":"23","author":"Puigdemont","year":"1990","journal-title":"J\u00a0Pharmacol Methods"},{"key":"10.1016\/j.cveq.2018.11.004_bib26","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJM200105313442201","article-title":"Effect of carvedilol on survival in severe chronic heart failure","volume":"344","author":"Packer","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cveq.2018.11.004_bib27","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/0002-9149(94)90308-5","article-title":"beta-Blocker therapy in the cardiac arrhythmia suppression trial. CAST investigators","volume":"74","author":"Kennedy","year":"1994","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cveq.2018.11.004_bib28","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/jvim.15055","article-title":"Effect of sotalol on heart rate, QT interval, and atrial fibrillation cycle length in horses with atrial fibrillation","volume":"32","author":"Decloedt","year":"2018","journal-title":"J\u00a0Vet Intern Med"},{"key":"10.1016\/j.cveq.2018.11.004_bib29","first-page":"430","article-title":"The use of transvenous electrical cardioversion for the treatment of atrial fibrillation in a British equine hospital population","volume":"26","author":"Prutton","year":"2012","journal-title":"J\u00a0Vet Intern Med"},{"key":"10.1016\/j.cveq.2018.11.004_bib30","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.tvjl.2015.09.021","article-title":"Pharmacokinetics of intravenously and orally administered sotalol hydrochloride in horses and effects on surface electrocardiogram and left ventricular systolic function","volume":"208","author":"Broux","year":"2016","journal-title":"Vet J"},{"key":"10.1016\/j.cveq.2018.11.004_bib31","series-title":"How to diagnose and treat ventricular tachycardia","first-page":"308","author":"House","year":"2009"},{"key":"10.1016\/j.cveq.2018.11.004_bib32","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.tvjl.2005.04.001","article-title":"Intravenous amiodarone treatment in horses with chronic atrial fibrillation","volume":"172","author":"De Clercq","year":"2006","journal-title":"Vet J"},{"key":"10.1016\/j.cveq.2018.11.004_bib33","doi-asserted-by":"crossref","first-page":"344","DOI":"10.2746\/042516407X182811","article-title":"Effects of an adapted intravenous amiodarone treatment protocol in horses with atrial fibrillation","volume":"39","author":"De Clercq","year":"2007","journal-title":"Equine Vet J"},{"key":"10.1016\/j.cveq.2018.11.004_bib34","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1111\/j.1939-1676.2007.tb03037.x","article-title":"Treatment with amiodarone of refractory ventricular tachycardia in a horse","volume":"21","author":"De Clercq","year":"2007","journal-title":"J\u00a0Vet Intern Med"},{"key":"10.1016\/j.cveq.2018.11.004_bib35","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.taap.2003.11.009","article-title":"Pharmacokinetics and pharmacodynamic effects of amiodarone in plasma of ponies after single intravenous administration","volume":"195","author":"Trachsel","year":"2004","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.cveq.2018.11.004_bib36","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/j.1939-1676.2005.tb02749.x","article-title":"Effects of diltiazem on hemodynamic variables and ventricular function in healthy horses","volume":"19","author":"Schwarzwald","year":"2005","journal-title":"J\u00a0Vet Intern Med"},{"key":"10.1016\/j.cveq.2018.11.004_bib37","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1939-1676.2007.tb02943.x","article-title":"Atrial, SA nodal, and AV nodal electrophysiology in standing horses: normal findings and electrophysiologic effects of quinidine and diltiazem","volume":"21","author":"Schwarzwald","year":"2007","journal-title":"J\u00a0Vet Intern Med"},{"key":"10.1016\/j.cveq.2018.11.004_bib38","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.2460\/javma.250.9.1027","article-title":"Cardiovascular findings in ponies with equine metabolic syndrome","volume":"250","author":"Heliczer","year":"2017","journal-title":"J\u00a0Am Vet Med Assoc"},{"key":"10.1016\/j.cveq.2018.11.004_bib39","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1046\/j.1365-2796.2000.00585.x","article-title":"Hypomagnesemia in heart failure with ventricular arrhythmias. Beneficial effects of magnesium supplementation","volume":"247","author":"Ceremuzynski","year":"2000","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.cveq.2018.11.004_bib40","doi-asserted-by":"crossref","first-page":"C452","DOI":"10.1152\/ajpcell.1989.256.2.C452","article-title":"Cytosolic magnesium modulates calcium channel activity in mammalian ventricular cells","volume":"256","author":"Agus","year":"1989","journal-title":"Am J Physiol"},{"key":"10.1016\/j.cveq.2018.11.004_bib41","first-page":"99","article-title":"Modification of cardiopulmonary and intestinal motility effects of xylazine with glycopyrrolate in horses","volume":"61","author":"Singh","year":"1997","journal-title":"Can J Vet Res"},{"key":"10.1016\/j.cveq.2018.11.004_bib42","doi-asserted-by":"crossref","first-page":"456","DOI":"10.2460\/ajvr.2004.65.456","article-title":"Effects of glycopyrrolate on cardiorespiratory function in horses anesthetized with halothane and xylazine","volume":"65","author":"Teixeira Neto","year":"2004","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.cveq.2018.11.004_bib43","first-page":"29","article-title":"Effects of intravenously administered glycopyrrolate in anesthetized horses","volume":"40","author":"Dyson","year":"1999","journal-title":"Can Vet J"},{"key":"10.1016\/j.cveq.2018.11.004_bib44","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1136\/vr.142.7.166","article-title":"Effects of hyoscine-N-butylbromide given before romifidine in horses","volume":"142","author":"Marques","year":"1998","journal-title":"Vet Rec"},{"key":"10.1016\/j.cveq.2018.11.004_bib45","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1136\/vr.129.17.378","article-title":"Analgesic and spasmolytic effects of dipyrone, hyoscine-N-butylbromide and a combination of the two in ponies","volume":"129","author":"Roelvink","year":"1991","journal-title":"Vet Rec"},{"key":"10.1016\/j.cveq.2018.11.004_bib46","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1467-2995.2005.00250.x","article-title":"The effect of hyoscine on dobutamine requirement in spontaneously breathing horses anaesthetized with halothane","volume":"33","author":"Borer","year":"2006","journal-title":"Vet Anaesth Analg"},{"key":"10.1016\/j.cveq.2018.11.004_bib47","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1111\/j.1939-1676.2008.0150.x","article-title":"Effect of pimobendan or benazepril hydrochloride on survival times in dogs with congestive heart failure caused by naturally occurring myxomatous mitral valve disease: the QUEST study","volume":"22","author":"Haggstrom","year":"2008","journal-title":"J\u00a0Vet Intern Med"},{"key":"10.1016\/j.cveq.2018.11.004_bib48","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1111\/jvim.14586","article-title":"Effect of pimobendan in dogs with preclinical myxomatous mitral valve disease and cardiomegaly: the EPIC Study - a randomized clinical trial","volume":"30","author":"Boswood","year":"2016","journal-title":"J\u00a0Vet Intern Med"},{"key":"10.1016\/j.cveq.2018.11.004_bib49","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/jvim.14885","article-title":"Longitudinal analysis of quality of life, clinical, radiographic, echocardiographic, and laboratory variables in dogs with preclinical myxomatous mitral valve disease receiving pimobendan or placebo: the EPIC study","volume":"32","author":"Boswood","year":"2018","journal-title":"J\u00a0Vet Intern Med"},{"key":"10.1016\/j.cveq.2018.11.004_bib50","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.2460\/ajvr.1976.37.10.1177","article-title":"Acute hemodynamic effects of furosemide administered intravenously in the horse","volume":"37","author":"Muir","year":"1976","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.cveq.2018.11.004_bib51","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/j.1939-1676.2004.tb02614.x","article-title":"Pharmacokinetics and pharmacodynamics of furosemide after oral administration to horses","volume":"18","author":"Johansson","year":"2004","journal-title":"J\u00a0Vet Intern Med"},{"key":"10.1016\/j.cveq.2018.11.004_bib52","first-page":"216","article-title":"The pharmacology of furosemide in the horse. III. Dose and time response relationships, effects of repeated dosing. and performance effects","volume":"2","author":"Tobin","year":"1978","journal-title":"J\u00a0Equine Med Surg"},{"key":"10.1016\/j.cveq.2018.11.004_bib53","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/j.1939-1676.2003.tb02529.x","article-title":"Furosemide continuous rate infusion in the horse: evaluation of enhanced efficacy and reduced side effects","volume":"17","author":"Johansson","year":"2003","journal-title":"J\u00a0Vet Intern Med"},{"key":"10.1016\/j.cveq.2018.11.004_bib54","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1161\/HYPERTENSIONAHA.111.172700","article-title":"New take on the role of angiotensin II in cardiac hypertrophy and fibrosis","volume":"57","author":"Kurdi","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.cveq.2018.11.004_bib55","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1056\/NEJM198706043162301","article-title":"Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)","volume":"316","author":"Group","year":"1987","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cveq.2018.11.004_bib56","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.2460\/javma.1998.213.11.1573","article-title":"Effects of enalapril maleate on survival of dogs with naturally acquired heart failure. The Long-Term Investigation of Veterinary Enalapril (LIVE) Study Group","volume":"213","author":"Ettinger","year":"1998","journal-title":"J\u00a0Am Vet Med Assoc"},{"key":"10.1016\/j.cveq.2018.11.004_bib57","doi-asserted-by":"crossref","first-page":"60A","DOI":"10.1016\/S0002-9149(88)80087-0","article-title":"Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)","volume":"62","author":"Swedberg","year":"1988","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cveq.2018.11.004_bib58","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1161\/01.CIR.82.5.1724","article-title":"Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD)","volume":"82","author":"Francis","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.cveq.2018.11.004_bib59","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.2460\/javma.231.7.1061","article-title":"Results of the veterinary enalapril trial to prove reduction in onset of heart failure in dogs chronically treated with enalapril alone for compensated, naturally occurring mitral valve insufficiency","volume":"231","author":"Atkins","year":"2007","journal-title":"J\u00a0Am Vet Med Assoc"},{"key":"10.1016\/j.cveq.2018.11.004_bib60","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1161\/01.CIR.101.22.2612","article-title":"Angiotensin II antagonist prevents electrical remodeling in atrial fibrillation","volume":"101","author":"Nakashima","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.cveq.2018.11.004_bib61","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1161\/hc4601.099402","article-title":"Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure","volume":"104","author":"Li","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.cveq.2018.11.004_bib62","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1111\/jvim.12153","article-title":"Pharmacodynamic evaluation of 4 angiotensin-converting enzyme inhibitors in healthy adult horses","volume":"27","author":"Afonso","year":"2013","journal-title":"J\u00a0Vet Intern Med"},{"key":"10.1016\/j.cveq.2018.11.004_bib63","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/evj.12773","article-title":"Preliminary investigation of orally administered benazepril in horses with left-sided valvular regurgitation","volume":"50","author":"Afonso","year":"2018","journal-title":"Equine Vet J"},{"issue":"7","key":"10.1016\/j.cveq.2018.11.004_bib64","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.2042-3306.1989.tb05662.x","article-title":"Serum angiotensin converting enzyme activity and response to angiotensin I in horses","author":"Tillman","year":"1989","journal-title":"Equine Vet J Suppl"},{"key":"10.1016\/j.cveq.2018.11.004_bib65","first-page":"111","article-title":"Chronic oral therapy with enalapril in normal ponies","volume":"10","author":"Sleeper","year":"2008","journal-title":"J\u00a0Vet Cardiol"},{"key":"10.1016\/j.cveq.2018.11.004_bib66","first-page":"231","article-title":"Characterization of the pharmacokinetic and pharmacodynamic properties of the angiotensin-converting enzyme inhibitor, enalapril, in horses","volume":"18","author":"Gardner","year":"2004","journal-title":"J\u00a0Vet Intern Med"},{"key":"10.1016\/j.cveq.2018.11.004_bib67","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/evj.12206","article-title":"Effects of quinapril on angiotensin converting enzyme and plasma renin activity as well as pharmacokinetic parameters of quinapril and its active metabolite, quinaprilat, after intravenous and oral administration to mature horses","volume":"46","author":"Davis","year":"2013","journal-title":"Equine Vet J"},{"key":"10.1016\/j.cveq.2018.11.004_bib68","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1046\/j.1439-0442.2003.00580.x","article-title":"Effects of the ACE inhibitor quinapril on echocardiographic variables in horses with mitral valve insufficiency","volume":"50","author":"Gehlen","year":"2003","journal-title":"J\u00a0Vet Med A Physiol Pathol Clin Med"},{"key":"10.1016\/j.cveq.2018.11.004_bib69","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cveq.2018.11.004_bib70","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1939-1676.2009.0467.x","article-title":"Efficacy of spironolactone on survival in dogs with naturally occurring mitral regurgitation caused by myxomatous mitral valve disease","volume":"24","author":"Bernay","year":"2010","journal-title":"J\u00a0Vet Intern Med"},{"key":"10.1016\/j.cveq.2018.11.004_bib71","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1006\/jmcc.2000.1129","article-title":"Induction of cardiac fibrosis by aldosterone","volume":"32","author":"Lijnen","year":"2000","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.cveq.2018.11.004_bib72","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0014-2999(98)00701-8","article-title":"Hydralazine-induced vasodilation involves opening of high conductance Ca2+-activated K+ channels","volume":"361","author":"Bang","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.cveq.2018.11.004_bib73","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0002-9149(83)90127-3","article-title":"Determinants of circulatory response to intravenous hydralazine in congestive heart failure","volume":"52","author":"Wilson","year":"1983","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cveq.2018.11.004_bib74","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/0735-1097(94)90868-0","article-title":"Vasodilator therapy in chronic asymptomatic aortic regurgitation: enalapril versus hydralazine therapy","volume":"24","author":"Lin","year":"1994","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cveq.2018.11.004_bib75","doi-asserted-by":"crossref","first-page":"618","DOI":"10.2460\/ajvr.1988.49.05.618","article-title":"Cardiovascular effects of hydralazine HCl administration in horses","volume":"49","author":"Bertone","year":"1988","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.cveq.2018.11.004_bib76","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.2042-3306.1996.tb01586.x","article-title":"Nitric oxide donors as treatment for grass induced acute laminitis in ponies","volume":"28","author":"Hinckley","year":"1996","journal-title":"Equine Vet J"},{"key":"10.1016\/j.cveq.2018.11.004_bib77","series-title":"Small animal cardiovascular medicine","first-page":"192","article-title":"Management of heart failure","author":"Kittleson","year":"1998"},{"key":"10.1016\/j.cveq.2018.11.004_bib78","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1358\/dot.2008.44.12.1131826","article-title":"Isosorbide dinitrate\/hydralazine: its role in the treatment of heart failure","volume":"44","author":"Thadani","year":"2008","journal-title":"Drugs Today (Barc)"},{"key":"10.1016\/j.cveq.2018.11.004_bib79","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/ppul.20229","article-title":"Sildenafil and an early stage of chronic hypoxia-induced pulmonary hypertension in newborn piglets","volume":"40","author":"Binns-Loveman","year":"2005","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.cveq.2018.11.004_bib80","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1542\/peds.2005-0523","article-title":"Oral sildenafil in infants with persistent pulmonary hypertension of the newborn: a pilot randomized blinded study","volume":"117","author":"Baquero","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.cveq.2018.11.004_bib81","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.cveq.2005.04.002","article-title":"Ventilatory support of the critically ill foal","volume":"21","author":"Palmer","year":"2005","journal-title":"Vet Clin North Am Equine Pract"},{"key":"10.1016\/j.cveq.2018.11.004_bib82","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0749-0739(17)30759-9","article-title":"Pharmacology and pharmacokinetics of drugs used to treat cardiac disease in horses","volume":"1","author":"Muir","year":"1985","journal-title":"Vet Clin North Am Equine Pract"},{"key":"10.1016\/j.cveq.2018.11.004_bib83","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.2460\/ajvr.1980.41.09.1388","article-title":"Digoxin pharmacokinetics, bioavailability, efficacy, and dosage regimens in the horse","volume":"41","author":"Button","year":"1980","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.cveq.2018.11.004_bib84","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.2460\/ajvr.1993.54.07.1108","article-title":"Pharmacokinetics of digoxin administered to horses with congestive heart failure","volume":"54","author":"Sweeney","year":"1993","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.cveq.2018.11.004_bib85","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.2460\/ajvr.1981.42.08.1412","article-title":"Pharmacokinetics of a single, orally administered dose of digoxin in horses","volume":"42","author":"Pedersoli","year":"1981","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.cveq.2018.11.004_bib86","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S0034-5288(18)33483-0","article-title":"Pharmacological experiments as a basis for the administration of digoxin in the horse","volume":"20","author":"Francfort","year":"1976","journal-title":"Res Vet Sci"},{"key":"10.1016\/j.cveq.2018.11.004_bib87","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1939-1676.1991.tb00936.x","article-title":"Hemodynamic effects of atropine, dobutamine, nitroprusside, phenylephrine, and propranolol in conscious horses","volume":"5","author":"Hinchcliff","year":"1991","journal-title":"J\u00a0Vet Intern Med"},{"key":"10.1016\/j.cveq.2018.11.004_bib88","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2460\/javma.1983.182.03.267","article-title":"Uroperitoneum in the foal","volume":"182","author":"Richardson","year":"1983","journal-title":"J\u00a0Am Vet Med Assoc"},{"key":"10.1016\/j.cveq.2018.11.004_bib89","first-page":"H237","article-title":"Myocardial oxygen consumption: effects of epinephrine, isoproterenol, dopamine, norepinephrine, and dobutamine","volume":"235","author":"Vasu","year":"1978","journal-title":"Am J Physiol"},{"key":"10.1016\/j.cveq.2018.11.004_bib90","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/evj.12721","article-title":"Effects of dobutamine, dopamine, phenylephrine and noradrenaline on systemic haemodynamics and intestinal perfusion in isoflurane anaesthetised horses","volume":"50","author":"Dancker","year":"2018","journal-title":"Equine Vet J"},{"key":"10.1016\/j.cveq.2018.11.004_bib91","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.2460\/ajvr.1998.59.11.1463","article-title":"Effects of dopamine, dobutamine, dopexamine, phenylephrine, and saline solution on intramuscular blood flow and other cardiopulmonary variables in halothane-anesthetized ponies","volume":"59","author":"Lee","year":"1998","journal-title":"Am J Vet Res"},{"issue":"19","key":"10.1016\/j.cveq.2018.11.004_bib92","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.2042-3306.1995.tb04997.x","article-title":"The haemodynamic effects of milrinone HCl in halothane anaesthetised horses","author":"Muir","year":"1995","journal-title":"Equine Vet J Suppl"},{"key":"10.1016\/j.cveq.2018.11.004_bib93","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/jvim.13914","article-title":"Long-term outcome of Irish wolfhound dogs with preclinical cardiomyopathy, atrial fibrillation, or both treated with pimobendan, benazepril hydrochloride, or methyldigoxin monotherapy","volume":"30","author":"Vollmar","year":"2016","journal-title":"J\u00a0Vet Intern Med"},{"key":"10.1016\/j.cveq.2018.11.004_bib94","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/evj.12432","article-title":"Cardiovascular effects of pimobendan in healthy mature horses","volume":"48","author":"Afonso","year":"2016","journal-title":"Equine Vet J"}],"container-title":["Veterinary Clinics of North America: Equine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749073918300725?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749073918300725?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T04:18:40Z","timestamp":1760069920000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0749073918300725"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":94,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S0749073918300725"],"URL":"https:\/\/doi.org\/10.1016\/j.cveq.2018.11.004","relation":{},"ISSN":["0749-0739"],"issn-type":[{"value":"0749-0739","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiac Therapeutics in Horses","name":"articletitle","label":"Article Title"},{"value":"Veterinary Clinics of North America: Equine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cveq.2018.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}